Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Non-Current Assets (2020 - 2025)

Maravai Lifesciences Holdings has reported Non-Current Assets over the past 6 years, most recently at $474.3 million for Q4 2025.

  • Quarterly results put Non-Current Assets at $474.3 million for Q4 2025, down 18.09% from a year ago — trailing twelve months through Dec 2025 was $2.1 billion (down 22.04% YoY), and the annual figure for FY2025 was $474.3 million, down 18.09%.
  • Non-Current Assets for Q4 2025 was $474.3 million at Maravai Lifesciences Holdings, down from $523.3 million in the prior quarter.
  • Over the last five years, Non-Current Assets for MRVI hit a ceiling of $1.6 billion in Q3 2023 and a floor of $474.3 million in Q4 2025.
  • Median Non-Current Assets over the past 5 years was $941.5 million (2021), compared with a mean of $1.0 billion.
  • Biggest five-year swings in Non-Current Assets: skyrocketed 53.75% in 2022 and later tumbled 61.76% in 2024.
  • Maravai Lifesciences Holdings' Non-Current Assets stood at $1.2 billion in 2021, then increased by 21.74% to $1.4 billion in 2022, then plummeted by 45.1% to $787.5 million in 2023, then decreased by 26.47% to $579.1 million in 2024, then fell by 18.09% to $474.3 million in 2025.
  • The last three reported values for Non-Current Assets were $474.3 million (Q4 2025), $523.3 million (Q3 2025), and $537.2 million (Q2 2025) per Business Quant data.